LRRK2 is required for CD38-mediated NAADP-Ca2+ signaling and the downstream activation of TFEB (transcription factor EB) in immune cells-Reference-Cited by-同舟云学术

LRRK2 is required for CD38-mediated NAADP-Ca2+ signaling and the downstream activation of TFEB (transcription factor EB) in immune cells

Published:2021-07-27 Issue: Volume: Page:1-19
ISSN:1554-8627
Container-title:Autophagy
language:en
Short-container-title:Autophagy

Author:

Nabar Neel R.¹^ORCID,Heijjer Christopher N.¹,Shi Chong-Shan¹,Hwang Il-Young¹,Ganesan Sundar²,Karlsson Mikael C. I.³,Kehrl John H.¹^ORCID

Affiliation:

1. B Cell Molecular Immunology Section, Laboratory of Immunoregulation, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

2. Biological Imaging Section, Research Technologies Branch, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

3. Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, Sweden

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15548627.2021.1954779

Reference72 articles.

1. CD38 as an immunotherapeutic target in multiple myeloma

2. CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience